Deborah Rathjen

Deborah Rathjen is the Chief Executive Officer of Carina Biotech and the Executive Chair of Bioasis Technologies, Inc. Deborah is also a Member of the Biomedical Translation Fund and served as President & CEO of Prestwick Chemical PC SAS, NEUROFIT, and Bionomics Ltd. Deborah has a PhD in Immunology from Macquarie University and a BSc(Hons) in Immunology from Flinders University.